Gilead Sciences (GILD) Beats Q4 Earnings Estimates by $0.03

Gilead Sciences (NASDAQ:GILD) reported quarterly earnings results on February 10, 2026 that exceeded analyst expectations.

The Healthcare company reported earnings per share of $1.86, beating the consensus estimate of $1.83 by $0.03 per share. Revenue came in at $7.9B, beating the estimate of $7.6B.

Gilead Sciences's stock moved following the earnings release. The stock currently trades at $152.57 with a market capitalization of $152.9B.